1. Home
  2. BCML vs NKTR Comparison

BCML vs NKTR Comparison

Compare BCML & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCML
  • NKTR
  • Stock Information
  • Founded
  • BCML 2004
  • NKTR 1990
  • Country
  • BCML United States
  • NKTR United States
  • Employees
  • BCML N/A
  • NKTR N/A
  • Industry
  • BCML Major Banks
  • NKTR Biotechnology: Pharmaceutical Preparations
  • Sector
  • BCML Finance
  • NKTR Health Care
  • Exchange
  • BCML Nasdaq
  • NKTR Nasdaq
  • Market Cap
  • BCML 261.8M
  • NKTR 238.7M
  • IPO Year
  • BCML N/A
  • NKTR 1994
  • Fundamental
  • Price
  • BCML $23.47
  • NKTR $1.32
  • Analyst Decision
  • BCML
  • NKTR Buy
  • Analyst Count
  • BCML 0
  • NKTR 4
  • Target Price
  • BCML N/A
  • NKTR $2.50
  • AVG Volume (30 Days)
  • BCML 20.3K
  • NKTR 988.9K
  • Earning Date
  • BCML 10-17-2024
  • NKTR 11-05-2024
  • Dividend Yield
  • BCML 1.70%
  • NKTR N/A
  • EPS Growth
  • BCML N/A
  • NKTR N/A
  • EPS
  • BCML 2.12
  • NKTR N/A
  • Revenue
  • BCML $97,490,000.00
  • NKTR $93,157,000.00
  • Revenue This Year
  • BCML N/A
  • NKTR N/A
  • Revenue Next Year
  • BCML $3.40
  • NKTR N/A
  • P/E Ratio
  • BCML $11.07
  • NKTR N/A
  • Revenue Growth
  • BCML N/A
  • NKTR 6.17
  • 52 Week Low
  • BCML $18.54
  • NKTR $0.41
  • 52 Week High
  • BCML $25.04
  • NKTR $1.93
  • Technical
  • Relative Strength Index (RSI)
  • BCML 54.44
  • NKTR 56.07
  • Support Level
  • BCML $23.09
  • NKTR $1.11
  • Resistance Level
  • BCML $23.45
  • NKTR $1.39
  • Average True Range (ATR)
  • BCML 0.48
  • NKTR 0.09
  • MACD
  • BCML -0.06
  • NKTR 0.01
  • Stochastic Oscillator
  • BCML 21.71
  • NKTR 75.00

About BCML BayCom Corp

BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

Share on Social Networks: